共 6 条
Efficacy and Safety of Basal Insulin Fc versus Degludec Insulin: A Meta-Analysis of Randomized Controlled Trials
被引:0
作者:

Ayesh, Hazem
论文数: 0 引用数: 0
h-index: 0
机构:
Vanderbilt Univ, Med Ctr, Div Diabet Endocrinol & Metab, Dept Med, Nashville, TN USA Vanderbilt Univ, Med Ctr, Div Diabet Endocrinol & Metab, Dept Med, Nashville, TN USA

Ayesh, Suhail
论文数: 0 引用数: 0
h-index: 0
机构:
Gene Med Labs, Gaza, Palestine Vanderbilt Univ, Med Ctr, Div Diabet Endocrinol & Metab, Dept Med, Nashville, TN USA

Niswender, Kevin
论文数: 0 引用数: 0
h-index: 0
机构:
Vanderbilt Univ, Med Ctr, Div Diabet Endocrinol & Metab, Dept Med, Nashville, TN USA Vanderbilt Univ, Med Ctr, Div Diabet Endocrinol & Metab, Dept Med, Nashville, TN USA
机构:
[1] Vanderbilt Univ, Med Ctr, Div Diabet Endocrinol & Metab, Dept Med, Nashville, TN USA
[2] Gene Med Labs, Gaza, Palestine
关键词:
D O I:
10.1097/MJT.0000000000001738
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
[No abstract available]
引用
收藏
页码:e588 / e591
页数:4
相关论文
共 6 条
- [1] Once-Weekly Basal Insulin Fc Demonstrated Similar Glycemic Control to Once-Daily Insulin Degludec in Insulin-Naive Patients With Type 2 Diabetes: A Phase 2 Randomized Control Trial[J]. DIABETES CARE, 2023, 46 (05) : 1060 - 1067Bue-Valleskey, Juliana M.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46225 USA Eli Lilly & Co, Indianapolis, IN 46225 USAKazda, Christof M.论文数: 0 引用数: 0 h-index: 0机构: Lilly France, Neuilly Sur Seine, France Eli Lilly & Co, Indianapolis, IN 46225 USAMa, Chenchen论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46225 USA Eli Lilly & Co, Indianapolis, IN 46225 USAChien, Jenny论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46225 USA Eli Lilly & Co, Indianapolis, IN 46225 USAZhang, Qianyi论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46225 USA Eli Lilly & Co, Indianapolis, IN 46225 USAChigutsa, Emmanuel论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46225 USA Eli Lilly & Co, Indianapolis, IN 46225 USALandschulz, William论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46225 USA Eli Lilly & Co, Indianapolis, IN 46225 USAHaupt, Axel论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46225 USA Eli Lilly & Co, Indianapolis, IN 46225 USAFrias, Juan P.论文数: 0 引用数: 0 h-index: 0机构: Veloc Clin Res, Los Angeles, CA USA Eli Lilly & Co, Indianapolis, IN 46225 USA
- [2] Safety and efficacy of once-weekly basal insulin Fc in people with type 2 diabetes previously treated with basal insulin: a multicentre, open-label, randomised, phase 2 study[J]. LANCET DIABETES & ENDOCRINOLOGY, 2023, 11 (03) : 158 - 168Frias, Juan论文数: 0 引用数: 0 h-index: 0机构: Veloc Clin Res, Los Angeles, CA USA Veloc Clin Res, Los Angeles, CA USAChien, Jenny论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN USA Veloc Clin Res, Los Angeles, CA USAZhang, Qianyi论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN USA Veloc Clin Res, Los Angeles, CA USAChigutsa, Emmanuel论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN USA Veloc Clin Res, Los Angeles, CA USALandschulz, William论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN USA Veloc Clin Res, Los Angeles, CA USASyring, Kristen论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN USA Veloc Clin Res, Los Angeles, CA USAWullenweber, Paula论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN USA Veloc Clin Res, Los Angeles, CA USAHaupt, Axel论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN USA Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA Veloc Clin Res, Los Angeles, CA USAKazda, Christof论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN USA Veloc Clin Res, Los Angeles, CA USA
- [3] Pharmacokinetic and pharmacodynamic properties of the novel basal insulin Fc (insulin efsitora alfa), an insulin fusion protein in development for once-weekly dosing for the treatment of patients with diabetes[J]. DIABETES OBESITY & METABOLISM, 2023, 25 (04) : 1080 - 1090Heise, Tim论文数: 0 引用数: 0 h-index: 0机构: Profil, Neuss, Germany Profil, Neuss, GermanyChien, Jenny论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN USA Profil, Neuss, GermanyBeals, John M.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN USA Profil, Neuss, GermanyBenson, Charles论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN USA Profil, Neuss, GermanyKlein, Oliver论文数: 0 引用数: 0 h-index: 0机构: Profil, Neuss, Germany Profil, Neuss, GermanyMoyers, Julie S.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN USA Profil, Neuss, GermanyHaupt, Axel论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN USA Profil, Neuss, GermanyPratt, Edward John论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN USA Lilly Ctr Clin Pharmacol Pte Ltd, 3 Biopolis Dr,02-11 Synapse, Singapore 138623, Singapore Profil, Neuss, Germany
- [4] Novel Once-Weekly Basal Insulin Fc Achieved Similar Glycemic Control With a Safety Profile Comparable to Insulin Degludec in Patients With Type 1 Diabetes[J]. DIABETES CARE, 2023, 46 (05) : 1052 - 1059Kazda, Christof M.论文数: 0 引用数: 0 h-index: 0机构: Lilly France, Neuilly Sur Seine, France Lilly France, Neuilly Sur Seine, FranceBue-Valleskey, Juliana M.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN USA Lilly France, Neuilly Sur Seine, FranceChien, Jenny论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN USA Lilly France, Neuilly Sur Seine, FranceZhang, Qianyi论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN USA Lilly France, Neuilly Sur Seine, FranceChigutsa, Emmanuel论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN USA Lilly France, Neuilly Sur Seine, FranceLandschulz, William论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN USA Lilly France, Neuilly Sur Seine, FranceWullenweber, Paula论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN USA Lilly France, Neuilly Sur Seine, FranceHaupt, Axel论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN USA Lilly France, Neuilly Sur Seine, FranceDahl, Dominik论文数: 0 引用数: 0 h-index: 0机构: Gemeinschaftspraxis Innere Med & Diabetol, Hamburg, Germany Lilly France, Neuilly Sur Seine, France
- [5] Preclinical Characterization of LY3209590, a Novel Weekly Basal Insulin Fc-Fusion Protein[J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2022, 382 (03) : 346 - 355Moyers, Julie S.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN USA Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN USAHansen, Ryan J.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN USADay, Jonathan W.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN USADickinson, Craig D.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, San Diego, CA USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN USAZhang, Chen论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN USARuan, Xiaoping论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN USADing, Liyun论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN USABrown, Robin M.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN USABaker, Hana E.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN USABeals, John M.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, San Diego, CA USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN USA
- [6] The Basis for Weekly Insulin Therapy: Evolving Evidence With Insulin Icodec and Insulin Efsitora Alfa[J]. ENDOCRINE REVIEWS, 2024, 45 (03) : 379 - 413Rosenstock, Julio论文数: 0 引用数: 0 h-index: 0机构: Veloc Clin Res Med City, 7777 Forest Ln,C-685, Dallas, TX 75230 USA Veloc Clin Res Med City, 7777 Forest Ln,C-685, Dallas, TX 75230 USAJuneja, Rattan论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Diabet & Obes, Indianapolis, IN 46225 USA Veloc Clin Res Med City, 7777 Forest Ln,C-685, Dallas, TX 75230 USABeals, John M.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Diabet & Obes, Indianapolis, IN 46225 USA Veloc Clin Res Med City, 7777 Forest Ln,C-685, Dallas, TX 75230 USAMoyers, Julie S.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Diabet & Obes, Indianapolis, IN 46225 USA Veloc Clin Res Med City, 7777 Forest Ln,C-685, Dallas, TX 75230 USAIlag, Liza论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Diabet & Obes, Indianapolis, IN 46225 USA Veloc Clin Res Med City, 7777 Forest Ln,C-685, Dallas, TX 75230 USAMcCrimmon, Rory J.论文数: 0 引用数: 0 h-index: 0机构: Univ Dundee, Sch Med, Dundee DD1 9SY, Scotland Veloc Clin Res Med City, 7777 Forest Ln,C-685, Dallas, TX 75230 USA